The therapeutic effects of marine sulfated polysaccharides on diabetic nephropathy

被引:3
|
作者
Wu, Lijuan [1 ,2 ,3 ]
Zhang, Xiaonan [2 ,3 ]
Zhao, Jun [2 ,3 ]
Yang, Menglin [2 ,3 ]
Yang, Jinbo [1 ,2 ,3 ]
Qiu, Peiju [1 ,2 ,3 ]
机构
[1] Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Yushan Rd, Qingdao 266003, Peoples R China
[2] Pilot Natl Lab Marine Sci & Technol Qingdao, Ctr Innovat Marine Drug Screening &Evaluat, Qingdao 266237, Peoples R China
[3] Marine Biomed Res Inst Qingdao, Qingdao 266071, Peoples R China
关键词
Marine sulfated polysaccharide; Diabetic nephropathy; Mechanisms; Structure-activity relationship; MOLECULAR-WEIGHT FUCOIDAN; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLAST-GROWTH-FACTOR; P-SELECTIN; STRUCTURAL-CHARACTERIZATION; ENDOTHELIAL GLYCOCALYX; HEPARANASE; BINDING; SULODEXIDE; DISEASE;
D O I
10.1016/j.ijbiomac.2024.129269
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Marine sulfated polysaccharide (MSP) is a natural high molecular polysaccharide containing sulfate groups, which widely exists in various marine organisms. The sources determine structural variabilities of MSPs which have high security and wide biological activities, such as anticoagulation, antitumor, antivirus, immune regulation, regulation of glucose and lipid metabolism, antioxidant, etc. Due to the structural similarities between MSP and endogenous heparan sulfate, a majority of studies have shown that MSP can be used to treat diabetic nephropathy (DN) in vivo and in vitro. In this paper, we reviewed the anti-DN activities, the dominant mechanisms and structure-activity relationship of MSPs in order to provide the overall scene of MSPs as a modality of treating DN.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Heparinoid-active sulfated polysaccharides from marine green algae
    Mao, Wenjun
    Sun, Haihong
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 606 - 606
  • [32] A wide diversity of sulfated polysaccharides are synthesized by different species of marine sponges
    Zierer, MS
    Mourao, PAS
    CARBOHYDRATE RESEARCH, 2000, 328 (02) : 209 - 216
  • [33] Insights into the structure-bioactivity relationships of marine sulfated polysaccharides: A review
    Kang, Ji
    Jia, Xing
    Wang, Nifei
    Xiao, Meng
    Song, Shuang
    Wu, Shufen
    Li, Zhenjing
    Wang, Shujun
    Cui, Steve W.
    Guo, Qingbin
    FOOD HYDROCOLLOIDS, 2022, 123
  • [34] A critical review on pharmacological properties of sulfated polysaccharides from marine macroalgae
    Jegadeshwari, B.
    Rajaram, R.
    CARBOHYDRATE POLYMERS, 2024, 344
  • [35] Therapeutic potential of angiostatin in diabetic nephropathy
    Zhang, SX
    Wang, JJ
    Lu, K
    Mott, R
    Ma, JX
    DIABETES, 2005, 54 : A211 - A211
  • [36] DIABETIC NEPHROPATHY - RECENT THERAPEUTIC CONCEPTS
    SCHMIDT, P
    WIENER KLINISCHE WOCHENSCHRIFT, 1990, 102 (05) : 121 - 125
  • [37] Recent therapeutic targets in diabetic nephropathy
    Mohsen, Marwa
    Elberry, Ahmed A.
    Rabea, Alaa Mohamed
    Abdelrahim, Mohamed E. A.
    Hussein, Raghda R. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (11)
  • [38] Pharmacodynamic parameters of anticoagulants based on sulfated polysaccharides from marine algae
    N. N. Drozd
    A. S. Tolstenkov
    V. A. Makarov
    T. A. Kuznetsova
    N. N. Besednova
    N. M. Shevchenko
    T. N. Zvyagintseva
    Bulletin of Experimental Biology and Medicine, 2006, 142 : 591 - 593
  • [39] Emerging therapeutic strategies in diabetic nephropathy
    Ravera, Maura
    Re, Michela
    Weiss, Ursula
    Deferrari, Luca
    Deferrari, Giacomo
    JOURNAL OF NEPHROLOGY, 2007, 20 : S23 - S32
  • [40] Fibrates: Therapeutic potential for diabetic nephropathy?
    Kouroumichakis, I.
    Papanas, N.
    Zarogoulidis, P.
    Liakopoulos, V.
    Maltezos, E.
    Mikhailidis, D. P.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (04) : 309 - 316